Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Investigators find pellet gun near scene where Toronto police killed suspected gunman

Published 05/27/2022, 04:09 PM
Updated 05/27/2022, 04:11 PM
© Reuters. FILE PHOTO: Police officers work at the scene where police shot and injured a suspect who was walking down a city street carrying a gun, as four nearby schools were placed on lockdown, in Toronto, Ontario, Canada, May 26, 2022. REUTERS/Chris Helgren

Ottawa (Reuters) - Investigators recovered a pellet gun from the scene where Toronto police shot and killed a man suspected of carrying a rifle in a section of the city that prompted five nearby schools to be placed under precautionary lockdowns.

On Thursday, police went to Scarborough after receiving multiple 911 calls about a man walking with a rifle and located him shortly after, Ontario province's Special Investigations Unit (SIU) said in a statement on Friday. The man, 27, was pronounced dead about 20 minutes later.

Toronto Police Chief James Ramer told reporters after the incident that officers responding to the calls were confronted by the man, but had declined to give further details, citing an ongoing investigation. This was after police said on Twitter (NYSE:TWTR) that officers had fired and injured the suspect.

The incident occurred days after a gunman in Texas killed 19 children and two teachers at an elementary school. The Texas shooting raised more concerns about growing gun violence.

Mass shootings are rare in Canada, where gun control laws are stricter than in the United States.

The investigation is ongoing and a post-mortem exam is scheduled for Saturday, said the SIU, which is an independent government agency tasked with investigating the conduct of officials, including police officers.

The SIU aims to complete its investigation within 120 days, which can vary depending on the case.

Canada's rate of firearm homicides is 0.5 per 100,000 people, far lower than the U.S. rate of 4.12, according to a 2021 analysis by the University of Washington's Institute for Health Metrics and Evaluation.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.